title: PERINATAL OUTCOMES OF PREMATURITY AND BIRTH WEIGHT ACCORDING TO MATERNAL CAFFEINE CONSUMPTION.
abstract: Objetive: identify whether there is an increased risk of adverse perinatal outcomes, like prematurity or decreased weight in newborns, associated with caffeine consumption during the first half of pregnancy in pregnant women of our population.
  
  
  METHODS
  transversal study carried out in 1 175 patients from Virgen de las Nieves University Hospital of Granada (Spain). Information about caffeine consumption during first half of gestation and perinatal outcomes was obtained by personal interview, medical records and telephone call after delivery. The average caffeine intake was calculated from meals and drinks included in a validated questionnaire.
  
  
  RESULTS
  there was no difference in caffeine consumption in pregnant women with birth weight ≥2 500 g and.
authors.affiliation: Obstetrics and Ginecology Service, Virgen de las Nieves University Hospital, Granada.. jmozasm@sego.es.
authors.forename: Natalia
authors.initials: N
authors.lastname: Del Castillo
authors.affiliation: Department of Preventive Medicine and Public Health, University of Granada, Granada. CIBER de Epidemiología y Salud Pública (CIBERESP). Instituto de Investigación Biosanitaria de Granada (Ibs.Granada). Complejo Hospitalario Universitario de Granada/Universidad de Granada.. jmozasm@sego.es.
authors.forename: José Juan
authors.initials: JJ
authors.lastname: Jiménez-Moleón
authors.affiliation: Department of Preventive Medicine and Public Health, University of Granada, Granada. CIBER de Epidemiología y Salud Pública (CIBERESP). Instituto de Investigación Biosanitaria de Granada (Ibs.Granada). Complejo Hospitalario Universitario de Granada/Universidad de Granada.. jmozasm@sego.es.
authors.forename: Rocío
authors.initials: R
authors.lastname: Olmedo-Requena
authors.affiliation: Department of Preventive Medicine and Public Health, University of Granada, Granada. CIBER de Epidemiología y Salud Pública (CIBERESP). Instituto de Investigación Biosanitaria de Granada (Ibs.Granada). Complejo Hospitalario Universitario de Granada/Universidad de Granada.. jmozasm@sego.es.
authors.forename: Virginia
authors.initials: V
authors.lastname: Martínez-Ruiz
authors.affiliation: Department of Preventive Medicine and Public Health, University of Granada, Granada. CIBER de Epidemiología y Salud Pública (CIBERESP). Instituto de Investigación Biosanitaria de Granada (Ibs.Granada). Complejo Hospitalario Universitario de Granada/Universidad de Granada.. jmozasm@sego.es.
authors.forename: Aurora
authors.initials: A
authors.lastname: Bueno-Cavanillas
authors.affiliation: Obstetrics and Ginecology Service, Virgen de las Nieves University Hospital, Granada. CIBER de Epidemiología y Salud Pública (CIBERESP). Instituto de Investigación Biosanitaria de Granada (Ibs.Granada). Complejo Hospitalario Universitario de Granada/Universidad de Granada. Department of Obstetrics and Ginecology, University of Granada, Granada, Spain.. jmozasm@sego.es.
authors.forename: Juan
authors.initials: J
authors.lastname: Mozas
mesh_terms: D000328:Adult; D001724:Birth Weight / Q000187:drug effects*; D002110:Caffeine / Q000009:adverse effects*; D003430:Cross-Sectional Studies; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007236:Infant, Small for Gestational Age; D011247:Pregnancy; D011256:Pregnancy Outcome; D047928:Premature Birth / Q000139:chemically induced* / Q000453:epidemiology; D013030:Spain / Q000453:epidemiology
chemical_list: D002110:Caffeine